Skip to main content
. Author manuscript; available in PMC: 2024 Apr 4.
Published in final edited form as: Eur J Surg Oncol. 2022 Jun 22;48(12):2448–2454. doi: 10.1016/j.ejso.2022.06.029

Table 3:

Subgroup univariate analysis of overall survival in patients selected by type of chemotherapy received. Abbreviations: HR: hazard ratio.

Treatment group N Hazard Ratio (95% CI) HR P-Value
Surgery + Multi-Agent Chemotherapy 795 0.40 (0.34–0.47) <0.001
Surgery + Single-Agent Chemotherapy 377 0.47 (0.39–0.57) <0.001
Multi-Agent Chemotherapy Alone 511 0.71 (0.60–0.85) <0.001
Single Agent Chemotherapy Alone 177 - -